Last reviewed · How we verify
NCT07522307: PSYTRAIL-80
Psychological Impact of an 80-km Ultra-Endurance Race
trial testing Completion on a tablet of self-administered questionnaires about their emotions/feelings before, during (kilometers 25, 38, 48, and 56), and at the finish line (80th kilometer) in Healthy Adult Participants in 80 participants. Currently enrolling.
30 March 2026
Quick facts
| Lead sponsor | Centre Hospitalier Régional d'Orléans |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 21 March 2026 |
| Primary completion | 30 March 2026 |
| Estimated completion | 30 March 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- Completion on a tablet of self-administered questionnaires about their emotions/feelings before, during (kilometers 25, 38, 48, and 56), and at the finish line (80th kilometer)
Conditions studied
- Healthy Adult Participants — all drugs for Healthy Adult Participants →
Sponsor
Centre Hospitalier Régional d'Orléans
Who can join
18 and older, any sex, with Healthy Adult Participants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ultra-endurance races (ultra-marathons) take place under extreme environmental conditions, over long distances, involving prolonged physical activity and multiple psychological and physiological challenges. These extreme conditions expose runners to a wide range of emotions-both pleasant and unpleasant-that can influence their performance, fatigue, and perception of exertion. Emotional intelligence and emotional regulation appear to be key determinants of emotional trajectories and performance in these contexts. Previous research shows that high levels of emotional intelligence and adaptive emotional regulation strategies are associated with functional emotional trajectories and better performance, whereas maladaptive strategies are linked to dysfunctional emotional trajectories and reduced performance. Furthermore, defense mechanisms constitute a complementary approach to emotional self-regulation. They can be adaptive or maladaptive and influence how runners cope with emotions and psychological stressors during competition. Longitudinal studies conducted to date have primarily explored post-race emotional trajectories in relation to emotional intelligence, without examining the impact of defense mechanisms on emotional dynamics during the race. Furthermore, few studies have examined the mediating role of emotional intensity between emotional regulation and perceived performance, and even fewer have adopted an approach that integrates physiological indicators such as heart rate or heart rate variability. Thus, this study lies at the intersection of sports psychology, emotion, and physiology, and aims to fill these gaps by exploring: 1. the influence of defense mechanisms on emotional dynamics and physical and mental fatigue during an ultra-endurance race, and 2. the mediating role of emotional intensity on the relationship between emotional regulation and perceived performance. The objective of this study is to examine how certain psychological mechanisms used to cope with difficult situations influence the evolution of emotions experienced by participants during and after an 80-kilometer ultra-endurance race.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07522307
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Adult Participants
Currently open trials in the same condition.
- NCT07352423 — Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy Participants · Phase 1 · recruiting
- NCT07522333 — Psychological Impact of an 120-km Ultra-Endurance Race · recruiting
- NCT07483606 — Turkish Validity and Reliability Study of PRevention of Toxic Chemicals in the Environment for Children Tool · recruiting
- NCT07357610 — An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healt · Phase 1 · recruiting
- NCT07335419 — A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine) · Phase 1 · active not recruiting
Other Centre Hospitalier Régional d'Orléans trials
Trials by the same sponsor.
- NCT07522333 — Psychological Impact of an 120-km Ultra-Endurance Race · recruiting
- NCT07334964 — Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method · NA · recruiting
- NCT07203807 — Study of the Optimal Number of Repetitions to Investigate the Cerebral Activity by fNIRS During a Voluntary Movement and · completed
- NCT07305701 — Cohort Study on Medical Students' Mental Health · recruiting
- NCT07085611 — Neutralizing Power of Serum Antibodies - 2 · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07522307 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Régional d'Orléans
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07522307.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing